Medicare Enrolled

Dr. Carl Goldsand, MD

Optician · Miami, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
16501 NW 2ND AVE, Miami, FL 33169
3053544558
In practice since 2005 (20 years)
NPI: 1447245212 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Goldsand from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Goldsand? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Goldsand

Dr. Carl Goldsand is an optician specialist in Miami, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Goldsand performed 366 Medicare services across 140 unique beneficiaries.

Between the years covered by Open Payments, Dr. Goldsand received a total of $7,358 from 28 pharmaceutical and/or device companies across 315 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Goldsand is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 366 Medicare services $7,358 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 26504 Clear January 31, 2027 —
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
366
Medicare services
Bottom 22% in FL for optician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
140
Unique beneficiaries
$151
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~18 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Dialysis services, 4 or more physician visits per month (20 years or older) 137 $290 $688
Office visit, established patient (20-29 min) 106 $58 $176
Office visit, established patient (30-39 min) 106 $71 $248
New patient office visit (45-59 min) 17 $116 $326
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,358
Total received (2018-2024)
Avg $1,051/year across 7 years
Top 18% in FL for optician
28
Companies
315
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,339 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$19 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,742
2023
$2,345
2022
$1,505
2021
$509
2020
$89
2019
$488
2018
$680

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,097
Mallinckrodt Hospital Products Inc.
$796
Vifor Pharma, Inc.
$659
Bayer Healthcare Pharmaceuticals Inc.
$639
Amgen Inc.
$579
Horizon Therapeutics plc
$520
Aurinia Pharma U.S., Inc.
$502
Bayer HealthCare Pharmaceuticals Inc.
$332
Otsuka America Pharmaceutical, Inc.
$325
ANI Pharmaceuticals, Inc.
$286
Travere Therapeutics, Inc.
$242
Boehringer Ingelheim Pharmaceuticals, Inc.
$195
Fresenius USA Marketing, Inc.
$167
Shire North American Group Inc
$145
Novartis Pharmaceuticals Corporation
$141
CALLIDITAS THERAPEUTICS US INC.
$128
Mallinckrodt LLC
$127
GlaxoSmithKline, LLC.
$88
Relypsa, Inc.
$71
Ardelyx, Inc.
$68
Mallinckrodt Enterprises LLC
$61
Genentech USA, Inc.
$46
Calliditas Therapeutics US Inc.
$40
AKEBIA THERAPEUTICS INC
$24
Novo Nordisk Inc
$21
Ultragenyx Pharmaceutical Inc.
$21
GENZYME CORPORATION
$20
OPKO Pharmaceuticals, LLC
$19
Top 3 companies account for 34.7% of total payments
Associated products mentioned in payments ›
ACTHAR · Aranesp · Auryxia · BENLYSTA · ENTRESTO · FABRY-DISEASE · FARXIGA · GATTEX · IBSRELA · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LOKELMA · LUPKYNIS · NATPARA · PURIFIED CORTROPHIN GEL · Parsabiv · RAYALDEE · Rituxan · Rybelsus · SAMSCA · TARPEYO · TAVNEOS · TERLIVAZ · Tavneos · Velphoro · Veltassa
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2,010 per 100 Medicare services performed
Looking for an optician specialist in Miami?
Compare opticians in the Miami area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
840
Per 100K population
31.3
County median income
$68,694
Nearest hospital
HCA FLORIDA AVENTURA HOSPITAL
4.8 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Goldsand is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 18% of FL peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Goldsand experienced with dialysis services, 4 or more physician visits per month (20 years or older)?
Based on Medicare claims data, Dr. Goldsand performed 137 dialysis services, 4 or more physician visits per month (20 years or older) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Goldsand receive payments from pharmaceutical companies?
Yes. Dr. Goldsand received a total of $7,358 from 28 companies across 315 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Goldsand's costs compare to other opticians in Miami?
Dr. Goldsand's average Medicare payment per service is $151. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Goldsand) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Opticians in Miami
Browse opticians in Miami ranked by procedure volume and transparency data.
Highest volume
Top Opticians in FL
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in FL
Which FL opticians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Mallinckrodt Hospital Products Inc. Payments to Doctors
See all physicians who received payments from Mallinckrodt Hospital Products Inc.
By company
Vifor Pharma, Inc. Payments to Doctors
See all physicians who received payments from Vifor Pharma, Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →